Skip to product information
1 of 1

Boehringer Ingelheim

J-VAC Coliform Mastitis

J-VAC Coliform Mastitis

Regular price $22.55 USD
Regular price Sale price $22.55 USD
Sale Sold out
Size

The only two-dose E.coli mastitis vaccine, J-Vac can be administered at any stage in lactation. So you can vaccinate with less effort, even in the humid months when risk is at its highest. For use in healthy cattle as an aid to protect against coliform mastitis caused by E.coli as well as endotoxemia caused by E. coli and Salmonella typhimurium. Safe to Use in Pregnant Animals. J-Vac offers superior protection from coliform mastitis in dairy cows. Protects cattle against endotoxemia associated with complex gram-negative diseases including coliform mastitis, other E. Coli infections, and salmonellosis. The organisms that cause coliform mastitis are widespread in the environment especially in hot, humid, or wet areas. The economic impact these can have on a herd can be devastating.

Given to healthy cattle, this vaccine aids in preventing E. coli mastitis. It can also reduce the effects of endotoxemia caused by E. coli and Salmonella typhimurium. The symptoms are fever, abnormal milk, significantly reduced milk production, udder edema, dehydration, and in severe cases death. Some animals may never recover fully. Vaccination and good herd management are key to prevention. As an aid in the prevention of mastitis: Administer one 2 ml dose intramuscularly or subcutaneously at 7 months gestation or at dry-off. Revaccinate at 1 to 3 weeks prior to calving. Revaccinate annually with the same protocol as above. As an aid in the prevention of the effects of endotoxemia: A whole herd vaccination may be done at any time. Vaccinate with a 2 ml dose followed by a second dose 2 to 4 weeks later. Revaccinate annually as above. 

Store away from heat or direct sunlight at 35-46°F (2-8°C). Do not freeze. Do not mix with other products. Use entire contents when first opened. Do not use chemicals to sterilize syringes and needles. Do not vaccinate within 21 days before slaughter. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine. In case of human exposure, contact.

Dosage: 2 mL IM or SQ repeat in 2-4 weeks. Repeat annually. 21 day slaughter withhold.

Manufacturer and/or Label Information

BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
3239 SATELLITE BLVD., BLDG 500, DULUTH, GA, 30096
Telephone: 800-325-9167
Customer Service: 800-243-0127
Fax: 816-236-2717
Website: www.boehringer-ingelheim.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
J-VAC®

Boehringer Ingelheim Animal Health

Escherichia Coli Bacterin-Toxoid

For use in animals only

Indications: This product has been shown to be effective for the vaccination of healthy cattle, including pregnant cows, against mastitis due to Escherichia coli and endotoxemia due to E. coli and Salmonella typhimurium. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity has not been determined. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Directions and dosage: Mix well before use. For vaccination against mastitis, inject one 2 mL dose intramuscularly or subcutaneously at 7 months of gestation or at dry off. Revaccinate 1 to 3 weeks before calving and upon each successive gestation, as above.

For vaccination against the effects of endotoxemia, whole herd vaccination may be done at any time. Vaccinate with one 2 mL dose followed by a second dose 2 to 4 weeks later. The presence of maternal antibody is known to interfere with the development of active immunity in calves and additional boosters will be required in most young animals.

Contact your veterinarian or the manufacturer for information on revaccination frequency.

Precautions: Store away from heat or direct sunlight at 35-46°F (2-8°C). Do not freeze. Do not mix with other products. Use entire contents when first opened. Do not use chemicals to sterilize syringes and needles. Do not vaccinate within 21 days before slaughter. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine. In case of human exposure, contact

a physician.

Preservatives: Gentamicin, nystatin, and thimerosal.

Boehringer Ingelheim Animal Health USA Inc., Athens, GA 30601

Phone: 1 (888) 637-4251

VLN/PCN 124/7850.00

J-VAC® is a registered trademark of Boehringer Ingelheim Animal Health USA Inc.



Product #:



10 doses/20 mL

126575

RM861R5

RM701R4

50 doses/100 mL

126573

RM865R5

RM705R4

125 doses/250 mL

126585

RM1002R3

RM1004R2

CPN: 1028344.0

COLORADO SERUM COMPANY4950 YORK STREET, P.O. BOX 16428, DENVER, CO, 80216-0428Telephone: 303-295-7527Order Desk: 800-525-2065Fax: 303-295-1923Website: www.colorado-serum.comEmail: colorado-serum@colorado-serum.comTHIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

TETANUS TOXOID-CONCENTRATED

Colorado Serum

Adjuvanted

GENERAL INFORMATION: This product has been shown to be effective for the vaccination of healthy horses, cattle, sheep, goats, and swine against tetanus. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity is unknown. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Safety in pregnant animals is unknown.

Tetanus Toxoid is prepared by detoxifying tetanus toxin in such a manner as to allow the antigenic properties to remain intact. Product is purified, concentrated and adjuvanted to provide a low dose effective immunizing agent.

Each serial is tested for purity, safety, and potency in accordance with USDA requirements.

Tetanus is caused by a neurotoxin produced by growth of Clostridium tetani, an anaerobic (lives without air) micro-organism, in necrotic tissue. Affected animals become stiff, have difficulty swallowing, and have an increased pulse rate. Breathing is labored. Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw.

Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw. Thus, the term “lockjaw” is often used. Legs and tail are often stiff with abdominal muscles contracted. Tetanus stricken animals may be unusually sensitive to light and heat. Temperature of the animal generally remains normal, elevating only shortly before death.

Protective antibody levels usually occur about two weeks after the second injection of the primary immunization series. In contrast, administration of Tetanus Antitoxin is recommended for immediate, emergency, passive treatment of exposed animals with unknown vaccination history or with signs of tetanus infection.

DIRECTIONS: Do not vaccinate within 21 days before slaughter. Store at 2-8° C. Do not freeze. Do not mix with other products. Shake well before use. Use entire contents when first opened.

PRECAUTIONS: A transitory local reaction may occur at injection site. Anaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent. In case of human exposure, consult a physician.

DOSAGE & ADMINISTRATION: For primary immunization, two doses should be administered subcutaneously or intramuscularly approximately 30 days apart. Use intramuscularly for horses as local reactions are more likely to occur if injected subcutaneously.

Horses: 1 ml IM

Cattle: 1 ml SC or IM

Sheep, Goats, Swine: 0.5 ml SC or IM

Historically, annual single dose revaccination has been recommended. Contact veterinarian for advice.

OTHER INFORMATION: Contains thimerosal and formalin as preservatives. Tetanus Toxoid Concentrate is available in single dose size packaged 10 vials to the carton, and in 10 dose vials.

THE PEAK OF QUALITY SINCE 1923

VLN: 188 / PCN: 8601.00

COLORADO SERUM COMPANY, 4950 York Street, Denver, Colorado 80216

303-295-752

www.colorado-serum.com

Contact us for information on other Colorado Serum Company products. Fine Veterinary Products since 1923.

FOR VETERINARY USE ONLY

 

 

Order #

10 - 1 ml vials

10 - 1 dose vials

11411

10 ml

10 doses

11415

CPN: 1101033.3

Dimensions

Care information

View full details